These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32298666)

  • 1. The mechanism of lncRNA H19 in fibrosis and its potential as novel therapeutic target.
    Jiang X; Ning Q
    Mech Ageing Dev; 2020 Jun; 188():111243. PubMed ID: 32298666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lncRNA H19 Mediates Pulmonary Fibrosis by Regulating the miR-196a/COL1A1 Axis.
    Lu Q; Guo Z; Xie W; Jin W; Zhu D; Chen S; Ren T
    Inflammation; 2018 Jun; 41(3):896-903. PubMed ID: 29411215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanisms and therapeutic potential of long noncoding RNA NEAT1 in fibrosis.
    Jiang X
    Clin Exp Med; 2023 Nov; 23(7):3339-3347. PubMed ID: 37740135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs as novel regulators, biomarkers and potential therapies in fibrosis.
    Jiang X; Ning Q
    Epigenomics; 2019 Jul; 11(9):1107-1116. PubMed ID: 31240943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA H19 Acts as a Competing Endogenous RNA to Mediate CTGF Expression by Sponging miR-455 in Cardiac Fibrosis.
    Huang ZW; Tian LH; Yang B; Guo RM
    DNA Cell Biol; 2017 Sep; 36(9):759-766. PubMed ID: 28753062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Paternally-Imprinted DLK1-MEG3 and IGF2-H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target.
    Sellers ZP; Schneider G; Maj M; Ratajczak MZ
    Stem Cell Rev Rep; 2018 Dec; 14(6):823-836. PubMed ID: 29980981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA: a new contributor and potential therapeutic target in fibrosis.
    Jiang X; Zhang F
    Epigenomics; 2017 Sep; 9(9):1233-1241. PubMed ID: 28809130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in cardiac fibroblast proliferation and fibrosis.
    Tao H; Cao W; Yang JJ; Shi KH; Zhou X; Liu LP; Li J
    Cardiovasc Pathol; 2016; 25(5):381-9. PubMed ID: 27318893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
    Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
    J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non coding RNA H19: An emerging therapeutic target in fibrosing diseases.
    Li J; Cao LT; Liu HH; Yin XD; Wang J
    Autoimmunity; 2020 Feb; 53(1):1-7. PubMed ID: 31646913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the long noncoding RNA H19 in TGF-β1-induced Tenon's capsule fibroblast proliferation and extracellular matrix deposition.
    Zhu H; Dai L; Li X; Zhang Z; Liu Y; Quan F; Zhang P; Yu L
    Exp Cell Res; 2020 Feb; 387(2):111802. PubMed ID: 31877306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.
    Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M
    Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA-H19 antagonism protects against renal fibrosis.
    Xie H; Xue JD; Chao F; Jin YF; Fu Q
    Oncotarget; 2016 Aug; 7(32):51473-51481. PubMed ID: 27391349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA: Shedding light on mechanisms and opportunities in fibrosis and aging.
    Yang Z; Jiang S; Shang J; Jiang Y; Dai Y; Xu B; Yu Y; Liang Z; Yang Y
    Ageing Res Rev; 2019 Jul; 52():17-31. PubMed ID: 30954650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis.
    Luan W; Zhou Z; Ni X; Xia Y; Wang J; Yan Y; Xu B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):531-542. PubMed ID: 29350287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-utero stress and mode of conception: impact on regulation of imprinted genes, fetal development and future health.
    Argyraki M; Damdimopoulou P; Chatzimeletiou K; Grimbizis GF; Tarlatzis BC; Syrrou M; Lambropoulos A
    Hum Reprod Update; 2019 Nov; 25(6):777-801. PubMed ID: 31633761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review.
    Hernández-Aguilar AI; Luciano-Villa CA; Tello-Flores VA; Beltrán-Anaya FO; Zubillaga-Guerrero MI; Flores-Alfaro E
    Expert Rev Mol Diagn; 2021 Aug; 21(8):809-821. PubMed ID: 34133256
    [No Abstract]   [Full Text] [Related]  

  • 18. The imprinted H19 noncoding RNA is a primary microRNA precursor.
    Cai X; Cullen BR
    RNA; 2007 Mar; 13(3):313-6. PubMed ID: 17237358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA H19 in the liver-gut axis: A diagnostic marker and therapeutic target for liver diseases.
    Li X; Liu R
    Exp Mol Pathol; 2020 Aug; 115():104472. PubMed ID: 32454104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced H19/YB-1 cascade modulates cardiac remodeling after infarction.
    Choong OK; Chen CY; Zhang J; Lin JH; Lin PJ; Ruan SC; Kamp TJ; Hsieh PCH
    Theranostics; 2019; 9(22):6550-6567. PubMed ID: 31588235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.